Floatz logo

273 assets in Metastatic Malignant Neoplasm

Therapeutic assets addressing Metastatic Malignant Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cbx-12
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P1C (39)
cd70-targeting car-t cells
Metastatic Malignant Neoplasm
Chongqing Precision Biotech Co., LtdP1C (39)
Ceritinib
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1C (39)
cf33-hnis
Metastatic Malignant Neoplasm
Imugene LimitedP1C (39)
Ckd-512
Metastatic Malignant Neoplasm
Chong Kun Dang PharmaceuticalP1C (39)
Copper-64 Fap-2286
Metastatic Malignant Neoplasm
Thomas HopeP1C (39)
Danburstotug
Metastatic Malignant Neoplasm
Mayo ClinicP1C (39)
Dat-2645
Metastatic Malignant Neoplasm
Danatlas Pharmaceuticals Co., LtdP1C (39)
ds3610a
Metastatic Malignant Neoplasm
Daiichi SankyoP1C (39)
ds-9606a
Metastatic Malignant Neoplasm
Daiichi SankyoP1C (39)
Edodekin Alfa
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P1C (39)
Elimusertib
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1C (39)
Elzovantinib
Metastatic Malignant Neoplasm
Turning Point Therapeutics, Inc.P1C (39)
Eras-0015
Metastatic Malignant Neoplasm
Erasca, Inc.P1C (39)
Eras-4001
Metastatic Malignant Neoplasm
Erasca, Inc.P1C (39)
Fam-Trastuzumab Deruxtecan-Nxki
Metastatic Malignant Neoplasm
QuantumLeap Healthcare CollaborativeP1C (39)
Fludeoxyglucose
Metastatic Malignant Neoplasm
Anusha KalbasiP1C (39)
Gallium-68 Labelled Fap-2286
Metastatic Malignant Neoplasm
Thomas HopeP1C (39)
Giloralimab
Metastatic Malignant Neoplasm
AbbVieP1C (39)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Metastatic Malignant Neoplasm
Anusha KalbasiP1C (39)
Inca33890
Metastatic Malignant Neoplasm
Incyte CorporationP1C (39)
IPH5301
Metastatic Malignant Neoplasm
Institut Paoli-CalmettesP1C (39)
jzp815
Metastatic Malignant Neoplasm
Jazz PharmaceuticalsP1C (39)
Lunresertib
Metastatic Malignant Neoplasm
University Health Network, TorontoP1C (39)
Mem-288 Intratumoral
Metastatic Malignant Neoplasm
Memgen, Inc.P1C (39)
MGC026
Metastatic Malignant Neoplasm
MacroGenicsP1C (39)
mk-0472
Metastatic Malignant Neoplasm
Merck Sharp & Dohme LLCP1C (39)
mk-1084
Metastatic Malignant Neoplasm
Merck Sharp & Dohme LLCP1C (39)
mq719
Metastatic Malignant Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (39)
Neratinib
Metastatic Malignant Neoplasm
OHSU Knight Cancer InstituteP1C (39)
Ntx-1088
Metastatic Malignant Neoplasm
Nectin Therapeutics LtdP1C (39)
Odc-Il2
Metastatic Malignant Neoplasm
Trutino Biosciences Inc.P1C (39)
Onm-501
Metastatic Malignant Neoplasm
OncoNano Medicine, Inc.P1C (39)
Pertuzumab
Metastatic Malignant Neoplasm
Seoul National University Bundang HospitalP1C (39)
Phox430
Metastatic Malignant Neoplasm
Phost'In TherapeuticsP1C (39)
Pidnarulex
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P1C (39)
Ptx-912
Metastatic Malignant Neoplasm
Proviva Therapeutics, Inc.P1C (39)
Pyruvate
Metastatic Malignant Neoplasm
Pamela MunsterP1C (39)
Revdofilimab
Metastatic Malignant Neoplasm
AbbVieP1C (39)
ro7566802
Metastatic Malignant Neoplasm
Genentech, Inc.P1C (39)
scd1 inhibitor mti-301
Metastatic Malignant Neoplasm
Mayo ClinicP1C (39)
skb107 for
Metastatic Malignant Neoplasm
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.P1C (39)
Slv-324 Intravenous
Metastatic Malignant Neoplasm
Solve TherapeuticsP1C (39)
Sonidegib
Metastatic Malignant Neoplasm
Mayo ClinicP1C (39)
sv-101
Metastatic Malignant Neoplasm
Williams Cancer FoundationP1C (39)
Tak-243
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P1C (39)
tj033721
Metastatic Malignant Neoplasm
I-Mab Biopharma US LimitedP1C (39)
tr-002
Metastatic Malignant Neoplasm
University of California, DavisP1C (39)
Trastuzumab Emtansine
Metastatic Malignant Neoplasm
Seoul National University Bundang HospitalP1C (39)
Tucatinib
Metastatic Malignant Neoplasm
QuantumLeap Healthcare CollaborativeP1C (39)
Showing 201 to 250 of 273 assets
PreviousPage 5 of 6Next